These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17678739)

  • 1. Promise of immune modulation to inhibit atherogenesis.
    Binder CJ; Hartvigsen K; Witztum JL
    J Am Coll Cardiol; 2007 Aug; 50(6):547-50. PubMed ID: 17678739
    [No Abstract]   [Full Text] [Related]  

  • 2. Phosphorylcholine-targeting immunization reduces atherosclerosis.
    Caligiuri G; Khallou-Laschet J; Vandaele M; Gaston AT; Delignat S; Mandet C; Kohler HV; Kaveri SV; Nicoletti A
    J Am Coll Cardiol; 2007 Aug; 50(6):540-6. PubMed ID: 17678738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidized LDL and anti-oxidized LDL antibodies in atherosclerosis - Novel insights and future directions in diagnosis and therapy.
    Hartley A; Haskard D; Khamis R
    Trends Cardiovasc Med; 2019 Jan; 29(1):22-26. PubMed ID: 29934015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidized-LDL immunization for the treatment of atherosclerosis: how far are we?
    Papageorgiou N; Tousoulis D
    Int J Cardiol; 2016 Nov; 222():93-94. PubMed ID: 27479549
    [No Abstract]   [Full Text] [Related]  

  • 5. Low level natural antibodies against phosphorylcholine: a novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease.
    Frostegård J
    Clin Immunol; 2010 Jan; 134(1):47-54. PubMed ID: 19748321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal immunization programs postnatal immune responses and reduces atherosclerosis in offspring.
    Yamashita T; Freigang S; Eberle C; Pattison J; Gupta S; Napoli C; Palinski W
    Circ Res; 2006 Sep; 99(7):e51-64. PubMed ID: 16946133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
    Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
    Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis.
    Binder CJ; Hartvigsen K; Chang MK; Miller M; Broide D; Palinski W; Curtiss LK; Corr M; Witztum JL
    J Clin Invest; 2004 Aug; 114(3):427-37. PubMed ID: 15286809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with malondialdehyde-modified low-density lipoprotein (LDL) reduces atherosclerosis in LDL receptor-deficient mice challenged with Porphyromonas gingivalis.
    Turunen SP; Kummu O; Wang C; Harila K; Mattila R; Sahlman M; Pussinen PJ; Hörkkö S
    Innate Immun; 2015 May; 21(4):370-85. PubMed ID: 25134521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural antibodies against phosphorylcholine in cardiovascular disease.
    de Faire U; Frostegård J
    Ann N Y Acad Sci; 2009 Sep; 1173():292-300. PubMed ID: 19758165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylcholine antibodies are diminished in ANCA-associated vasculitis.
    Wilde B; Slot M; van Paassen P; Theunissen R; Kemna M; Witzke O; Cohen Tervaert JW
    Eur J Clin Invest; 2015 Jul; 45(7):686-91. PubMed ID: 25940757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive immunity in atherogenesis: new insights and therapeutic approaches.
    Lichtman AH; Binder CJ; Tsimikas S; Witztum JL
    J Clin Invest; 2013 Jan; 123(1):27-36. PubMed ID: 23281407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The autoreactivity of anti-phosphorylcholine antibodies for atherosclerosis-associated neo-antigens and apoptotic cells.
    Shaw PX; Goodyear CS; Chang MK; Witztum JL; Silverman GJ
    J Immunol; 2003 Jun; 170(12):6151-7. PubMed ID: 12794145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rethinking oxidized low-density lipoprotein, its role in atherogenesis and the immune responses associated with it.
    Shaw PX
    Arch Immunol Ther Exp (Warsz); 2004; 52(4):225-39. PubMed ID: 15467487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune recognition of OxLDL in atherosclerosis.
    Kearney JF
    J Clin Invest; 2000 Jun; 105(12):1683-5. PubMed ID: 10862783
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension.
    Su J; Georgiades A; Wu R; Thulin T; de Faire U; Frostegård J
    Atherosclerosis; 2006 Sep; 188(1):160-6. PubMed ID: 16307748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin and atherosclerosis.
    Matsuura E; Kobayashi K; Inoue K; Shoenfeld Y
    Clin Rev Allergy Immunol; 2005 Dec; 29(3):311-9. PubMed ID: 16391407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.
    Binder CJ; Hörkkö S; Dewan A; Chang MK; Kieu EP; Goodyear CS; Shaw PX; Palinski W; Witztum JL; Silverman GJ
    Nat Med; 2003 Jun; 9(6):736-43. PubMed ID: 12740573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis.
    van Puijvelde GH; Hauer AD; de Vos P; van den Heuvel R; van Herwijnen MJ; van der Zee R; van Eden W; van Berkel TJ; Kuiper J
    Circulation; 2006 Oct; 114(18):1968-76. PubMed ID: 17060383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherosclerosis Susceptibility in Mice Is Independent of the V1 Immunoglobulin Heavy Chain Gene.
    Centa M; Gruber S; Nilsson D; Polyzos KA; Johansson DK; Hansson GK; Ketelhuth DF; Binder CJ; Malin S
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):25-36. PubMed ID: 26564818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.